When you have finished eating, and the food enters the intestine, a specialised group of cells present in the gut wall, known as L-cells, releases GLP-1 and GIP into the bloodstream (Figure 6) [5]
5-12 However, in clinical trials, including SURMOUNT-1 for tirzepatide and STEP 1 for semaglutide, participants were permitted to remain on a given dose for up to 4 additional weeks, as needed, to allow for the dissipation of any GI AEs
Patients need to carefully research options to make sure theyre getting high-quality care
What actually happens when you stop taking GLP-1 This is the section nobody wants to read
Muscle loss requires individual protein and training targets, assessed against actual lean mass rather than a generic guideline
Learn more about our editorial process